Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement and demyelinating disease: no MAC needed?

Scott R Barnum1, Alexander J Szalai

  • 1Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. sbarnum@uab.edu

Brain Research Reviews
|January 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immortalized Human Conjunctival Epithelial Cells Produce Functional Complement C3 and C4 Proteins.

Cornea·2023
Same author

Editorial: The impact of COVID-19 on immune system-related complications in surgical patients.

Frontiers in surgery·2023
Same author

Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study.

The Journal of rheumatology·2022
Same author

Periodontal Infection Aggravates C1q-Mediated Microglial Activation and Synapse Pruning in Alzheimer's Mice.

Frontiers in immunology·2022
Same author

Decreased Levels of STAT1 and Interferon-γ-Induced STAT1 Phosphorylation in Rheumatoid Arthritis CD4 and CD8 T Cells.

ACR open rheumatology·2021
Same author

Therapeutic Lowering of C-Reactive Protein.

Frontiers in immunology·2021
Same journal

Proceedings of a symposium: Camillo Golgi and Modern Neuroscience, September 29-October 1, 2009, Pavia, Italy.

Brain research reviews·2011
Same journal

The role of α oscillations in temporal attention.

Brain research reviews·2011
Same journal

Late-life depression and Alzheimer's disease: the glutamatergic system inside of this mirror relationship.

Brain research reviews·2011
Same journal

Friedreich's ataxia: past, present and future.

Brain research reviews·2011
Same journal

Cellular and molecular insights into neuropathy-induced pain hypersensitivity for mechanism-based treatment approaches.

Brain research reviews·2011
Same journal

Rabs, SNAREs and α-synuclein--membrane trafficking defects in synucleinopathies.

Brain research reviews·2011
See all related articles

The complement system

Area of Science:

  • Neuroimmunology
  • Complement System Biology

Background:

  • The complement system's role in demyelinating diseases, like multiple sclerosis, is traditionally attributed to the Membrane Attack Complex (MAC).
  • Previous understanding implicated MAC-mediated lysis of oligodendrocytes and neurons in disease pathogenesis.

Purpose of the Study:

  • To investigate the specific roles of complement system components, particularly C3 and C5, in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).
  • To re-evaluate the contribution of the MAC versus other complement fragments in demyelinating disease.

Main Methods:

  • Utilized genetically modified mouse models, including knockout mice for C3, C5, and their respective receptors, as well as transgenic mice with CNS-specific expression of C5a.
  • Assessed the frequency and intensity of EAE development in these models compared to wild-type counterparts.

Related Experiment Videos

Main Results:

  • Mice lacking C5 or the C5a receptor developed EAE with similar severity to wild-type mice, challenging the role of MAC.
  • Mice lacking C3 or its receptors showed attenuated EAE, while CNS-specific C3a expression led to severe EAE.
  • These findings indicate non-MAC-mediated mechanisms involving C3 fragments are crucial in EAE.

Conclusions:

  • C3-derived fragments, not C5 and the MAC, are likely the primary drivers of complement-mediated pathology in EAE.
  • This study reframes the understanding of complement's role in demyelinating diseases, highlighting C3a's pathogenic significance.